Eiger BioPharmaceuticals (EIGR) Short Interest Ratio & Short Volume

Notice: This company has been marked as potentially delisted and may not be actively trading.

Eiger BioPharmaceuticals Short Interest Data

Current Short Volume
Previous Short Volume
Change Vs. Previous Month
Dollar Volume Sold Short
Short Interest Ratio / Days to Cover
Last Record Date
March 31, 2024
Outstanding Shares
Float Size
Short Percent of Float
Today's Trading Volume
Average Trading Volume
Today's Volume Vs. Average
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Eiger BioPharmaceuticals ?

Sign up to receive the latest short interest report for Eiger BioPharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

EIGR Short Interest Over Time

EIGR Days to Cover Over Time

EIGR Percentage of Float Shorted Over Time

Eiger BioPharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/202429,800 shares $149,149.00 -11.3%2.3%0.3 $5.01
3/15/202433,600 shares $172,704.00 -18.8%2.6%2.8 $5.14
2/29/202441,400 shares $231,840.00 -2.1%3.2%4.2 $5.60
2/15/202442,300 shares $240,264.00 +27.0%3.2%4.7 $5.68
1/31/202433,300 shares $216,783.00 +14.0%2.5%3.8 $6.51
1/15/202429,200 shares $214,912.00 -7.3%2.2%2.8 $7.36
12/31/202331,500 shares $212,152.50 -97.1%2.1%2.9 $6.74
12/15/20231,070,000 shares $236,363.00 -7.0%N/A3.6 $0.22
11/30/20231,150,000 shares $391,115.00 +13.9%N/A3.5 $0.34
11/15/20231,010,000 shares $358,449.00 -5.6%N/A3.1 $0.35
10/31/20231,070,000 shares $279,270.00 No ChangeN/A3.1 $0.26
10/15/20231,070,000 shares $268,035.00 -7.8%N/A3.3 $0.25
9/30/20231,160,000 shares $353,800.00 -7.2%N/A4 $0.31
9/15/20231,250,000 shares $504,250.00 -0.8%N/A2.8 $0.40
8/31/20231,260,000 shares $1.09 million +4.1%N/A2.9 $0.86
8/15/20231,210,000 shares $738,100.00 +0.8%N/A2.7 $0.61
7/31/20231,200,000 shares $816,000.00 -9.8%N/A2.6 $0.68
7/15/20231,330,000 shares $1.04 million +26.7%N/A2.9 $0.78
6/30/20231,050,000 shares $739,200.00 -55.5%N/A2.1 $0.70
6/15/20232,360,000 shares $2.30 million -4.5%N/A6.2 $0.97
5/31/20232,470,000 shares $2.77 million +1.2%N/A7.4 $1.12
5/15/20232,440,000 shares $3.07 million -3.2%N/A7 $1.26
4/30/20232,520,000 shares $2.60 million -7.0%N/A4.7 $1.03
4/15/20232,710,000 shares $2.95 million +9.3%N/A4.3 $1.09
3/31/20232,480,000 shares $2.22 million +10.7%N/A3.7 $0.90
3/15/20232,240,000 shares $2.64 million +12.6%N/A3 $1.18
2/28/20231,990,000 shares $3.74 million -7.9%N/A1.7 $1.88
2/15/20232,160,000 shares $4.82 million +56.5%N/A1.9 $2.23
1/31/20231,380,000 shares $2.62 million +15.0%N/A1.2 $1.90
1/15/20231,200,000 shares $1.80 million -21.1%N/A1.3 $1.50
12/30/20221,520,000 shares $1.79 million -3.2%N/A1.7 $1.18
12/15/20221,570,000 shares $2.03 million +8.3%N/A2 $1.29
11/30/20221,450,000 shares $6.58 million -13.2%N/A2.5 $4.54
11/15/20221,670,000 shares $7.63 million -8.2%N/A4.9 $4.57
10/31/20221,820,000 shares $9.30 million -3.7%N/A5.3 $5.11
10/15/20221,890,000 shares $11.14 million -2.1%N/A5.7 $5.90
9/30/20221,930,000 shares $14.53 million +13.5%N/A6.3 $7.53
9/15/20221,700,000 shares $12.84 million -0.6%N/A5.4 $7.55
8/31/20221,710,000 shares $14.12 million -10.9%N/A5.3 $8.26
8/15/20221,920,000 shares $18.55 million -6.3%N/A5.9 $9.66
What’s Really Next for America… (Ad)

Millions of Unsuspecting Americans Could be Wiped Out… Yet those who watch this bombshell exposé and prepare before it’s too late could have the chance to protect their financial future and grow their wealth significantly.

Click here to stream this controversial exposé now.

EIGR Short Interest - Frequently Asked Questions

What is Eiger BioPharmaceuticals' current short interest?

Short interest is the volume of Eiger BioPharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 29,800 shares of EIGR short. 2.27% of Eiger BioPharmaceuticals' shares are currently sold short. Learn More on Eiger BioPharmaceuticals' current short interest.

What is a good short interest percentage for Eiger BioPharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.27% of Eiger BioPharmaceuticals' floating shares are currently sold short.

Is Eiger BioPharmaceuticals' short interest increasing or decreasing?

Eiger BioPharmaceuticals saw a decline in short interest during the month of March. As of March 31st, there was short interest totaling 29,800 shares, a decline of 11.3% from the previous total of 33,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Eiger BioPharmaceuticals' float size?

Eiger BioPharmaceuticals currently has issued a total of 1,480,000 shares. Some of Eiger BioPharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Eiger BioPharmaceuticals currently has a public float of 1,310,000 shares.

How does Eiger BioPharmaceuticals' short interest compare to its competitors?

2.27% of Eiger BioPharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Eiger BioPharmaceuticals: 60 Degrees Pharmaceuticals, Inc. (1.31%), Innovative Eyewear, Inc. (0.49%), Agile Therapeutics, Inc. (12.68%), Onconetix, Inc. (0.31%), Notable Labs, Ltd. (0.08%), Virpax Pharmaceuticals, Inc. (0.91%), Sonoma Pharmaceuticals, Inc. (0.30%), Salarius Pharmaceuticals, Inc. (1.65%), Mustang Bio, Inc. (0.91%), Zhongchao Inc. (11.72%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

What does it mean to sell short Eiger BioPharmaceuticals stock?

Short selling EIGR is an investing strategy that aims to generate trading profit from Eiger BioPharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Eiger BioPharmaceuticals?

A short squeeze for Eiger BioPharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of EIGR, which in turn drives the price of the stock up even further.

How often is Eiger BioPharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EIGR, twice per month. The most recent reporting period available is March, 31 2024.

More Short Interest Resources from MarketBeat

This page (NASDAQ:EIGR) was last updated on 5/18/2024 by MarketBeat.com Staff

From Our Partners